Deciphera Pharmaceuticals Inc (NASDAQ:DCPH)
| 15.08 Delayed Data As of 4:00pm ET |  +0.06 / +0.40%Today’s Change | 6.51 Today|||52-Week Range 20.88 | +54.35% Year-to-Date |
Latest DCPH News | Press Releases
No recent news for Deciphera Pharmaceuticals Inc.
Today’s Trading
| Previous close | 15.02 |
| Today’s open | 14.97 |
| Day’s range | 14.78 - 15.25 |
| Volume | 31,200 |
| Average volume (3 months) | 728,092 |
| Market cap | $1.1B |
Data as of 4:00pm ET, 12/06/2022
Growth & Valuation
| Earnings growth (last year) | -8.10% |
| Earnings growth (this year) | +51.67% |
| Earnings growth (next 5 years) | +21.00% |
| Revenue growth (last year) | +128.45% |
| P/E ratio | NM |
| Price/Sales | 5.90 |
| Price/Book | 3.01 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MORFMorphic Holding Inc | +0.10 | +0.38% |
| RGNXRegenxbio Inc | -0.51 | -2.21% |
| REPLReplimune Group Inc | -1.11 | -5.56% |
| BCYCBicycle Therapeutics... | +0.19 | +0.58% |
Data as of 4:00pm ET, 12/06/2022
Financials
| Next reporting date | March 15, 2023 |
| EPS forecast (this quarter) | -$0.58 |
| Annual revenue (last year) | $96.1M |
| Annual profit (last year) | -$300.0M |
| Net profit margin | -311.98% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Waltham, Massachusetts |
Forecasts
